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Abstract With the current resurgence of interest in the role of
mitochondrial [Ca2+] in energy production and cellular Ca2+
signalling, ruthenium red (RR) is being increasingly used as an
inhibitor of mitochondrial Ca2+ uptake. In the present study, the
effects of RR on cell and mitochondrial [Ca2+], and on cell
contractility were determined in isolated rat ventricular myocytes
subjected to adrenergic and electrical stimulation. At low
concentrations, 0^1 WM, RR inhibited mitochondrial Ca2+
uptake but this was a secondary effect due to a reduced total
intracellular [Ca2+], a conclusion supported by the ability of RR
to inhibit cell shortening. 5 WM RR completely inhibited cell
contraction, whereas higher concentrations, 10^25 WM, induced
spontaneous Ca2+ oscillations and contractile waves. These
results indicate that great care must be taken when using RR in
intact cells, and in interpreting any effects as resulting from a
primary inhibition of mitochondrial Ca2+ uptake. ß 2000 Fed-
eration of European Biochemical Societies. Published by Else-
vier Science B.V. All rights reserved.
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1. Introduction
There is currently a resurgence of interest in the role of
mitochondrial [Ca2] ([Ca2]m) in both cell energy production
and intracellular Ca2 signalling (reviewed in [1^3]). In non-
cardiac cell types, subpopulations of mitochondria situated
near sites of Ca2 release, such as those of the endoplasmic
reticulum, are capable of rapidly accumulating large amounts
of Ca2 [4^6]. In heart cells, however, the question of how
rapidly mitochondria take up Ca2 is controversial, especially
whether [Ca2]m changes during a single contraction [7^9].
Accumulation of Ca2 by mitochondria can rapidly activate
dehydrogenases of the citric acid cycle to increase NADH,
and hence ATP, production [1,4,5]. In heart cells, mitochon-
drial Ca2 transport is especially signi¢cant since the heart is
absolutely dependent on ATP from oxidative phosphorylation
for contraction. Furthermore, the large proportion of mito-
chondria within heart muscle gives them the potential to mod-
ulate cytosolic Ca2 levels, as found in other cell types [5,10].
However, this has yet to be demonstrated during the normal
excitation^contraction coupling cycle of the heart. In disease
states such as ischaemia/reperfusion injury, mitochondrial
Ca2 uptake may act as a double-edged sword; it can bu¡er
cytosolic [Ca2] ([Ca2]c), and thus protect the cell from Ca2
overload, but may also induce the mitochondrial permeability
transition pore, which would then prevent ATP resynthesis
upon reperfusion (reviewed in [11^13]).
Studies attempting to dissect the role of mitochondrial Ca2
transport in both physiological and pathological functioning
of the heart have relied largely on the use of inhibitors of the
mitochondrial Ca2 transporters: ruthenium red (RR), which
inhibits Ca2 entry via the Ca2 uniporter, and drugs like
diltiazem, clonazepam and CGP 37157, which inhibit Ca2
e¥ux by the mitochondrial Na/Ca2 exchanger [14^16]. All
these inhibitors are e¡ective in isolated mitochondria, but the
situation is more complicated in intact cells or organs. Diltia-
zem cannot be used since it is an inhibitor of sarcolemmal
Ca2 channels, CGP 37157 has been used in some non-cardiac
cell types, but appears to be unreliable for use in isolated
myocytes, and although clonazepam has been used success-
fully in isolated rat myocytes, it has yet to be tested in cells
from other species, or in whole hearts [16,17].
RR has, however, been widely used in both isolated hearts
and myocytes. Although known to a¡ect sarcoplasmic retic-
ular (SR) Ca2 transport, its action in protecting against is-
chaemia/reperfusion injury has been attributed to its ability to
inhibit mitochondrial Ca2 uptake [18^23]. The aim of the
present study was to determine whether low concentrations
of RR (0^5 WM) could inhibit mitochondrial Ca2 uptake in
isolated myocytes independently of e¡ects on [Ca2]c and
changes in cell contraction.
2. Materials and methods
2.1. Myocyte isolation
Single cardiac myocytes were isolated from rat ventricles by colla-
genase digestion [8]. Male Wistar rats (200^250 g) were killed by
cervical dislocation and the heart removed and placed in ice-cold
isolation bu¡er plus 0.75 mM CaCl2. Isolation bu¡er contained (in
mM): 20 sodium N-hydroxyethylpiperazine-NP-2-ethansulphonic acid
(HEPES), 130 NaCl, 4.5 KCl, 5 MgCl2, 1 NaH2PO4, 21 glucose,
5 Na-pyruvate, pH 7.25 with NaOH. The heart was perfused with
isolation bu¡er plus 0.75 mM CaCl2 at 37‡C for 4 min before switch-
ing to Ca2-free bu¡er (isolation bu¡er plus 90 WM EGTA) for 4 min.
The perfusate was then switched to ‘enzyme solution’ consisting of
50 ml isolation bu¡er plus 50 mg collagenase (Worthington, type I),
5 mg protease (Sigma, type XIV) and 15 WM CaCl2. The enzyme
solution was continued until the tissue felt soft; approximately
15 min. The heart was then washed with isolation bu¡er plus
150 WM CaCl2, ventricles removed, sliced approximately 10 times
and shaken for 5 min at 37‡C in 20^25 ml isolation bu¡er plus
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150 WM CaCl2. After ¢ltration the cells were allowed to sediment in
this bu¡er for 7 min. The supernatant was removed and cells resus-
pended in 0.5 mM CaCl2, the process repeated and cells ¢nally resus-
pended in approximately 15 ml of isolation bu¡er plus 2 mM CaCl2.
2.2. Measurement of [Ca2+]
[Ca2]m and total intracellular [Ca2] ([Ca2]i) were determined
using indo-1/AM. Cells were incubated with 10 WM indo-1/AM for
15 min at 30‡C, then centrifuged (1 min at 500Ug) and resuspended
in isolation bu¡er (containing 2 mM CaCl2); under these conditions
the dye partitions approximately equally between cytosolic and mito-
chondrial compartments [7,8].
For determination of total [Ca2]i, 1 mM probenecid was then
added to prevent leakage of indo-1 from the cytosol during cell stor-
age.
For determination of [Ca2]m, cells were incubated (without probe-
necid) at room temperature for 2 h, followed by 1.5 h at 37‡C. This
process, termed ‘heat-treatment’, promotes loss of cytosolic, but not
mitochondrial, indo-1 through sarcolemmal anion channels. Full de-
tails of the method and experiments to con¢rm the mitochondrial
origin of the remaining £uorescence are given in Gri⁄ths et al. [8].
2.3. Measurement of £uorescence and cell length
A small portion of the loaded cells was placed in an experimental
chamber which was mounted on the stage of an inverted microscope
(Nikon Diaphot 300). The normal superfusate contained (in mM):
137 NaCl, 5 KCl, 1.2 MgSO4, 1.2 NaH2PO4, 16 D-glucose, 1 CaCl2,
20 HEPES pH 7.4 (using NaOH), temperature 37‡C. The ‘low-Na’
solution used to induce cytosolic Ca2 loading (see Section 3) con-
tained 5 mM NaCl, 132 mM choline chloride (pH 7.4 using KOH).
The myocyte to be studied was illuminated with a red light and its
image visualised with a TV camera and monitor. Indo-1 was excited
at 340^390 nm and emission detected at 410 þ 5 and 490 þ 5 nm,
corresponding to the peak emissions of the Ca2-bound and Ca2-
free forms of the indicator, respectively. Fluorescence of the whole cell
was collected on-line by a Newcastle Photometric Systems Photon
Counting System (Newcastle, UK). Light was collected at a rate of
up to one data point/10 ms from a single myocyte following subtrac-
tion of background £uorescence. Cell length changes were monitored
using a Crescent Electronics Video Edge Motion Detector.
2.4. Calculation of [Ca2+]
To obtain values of [Ca2]i, the £uorescence ratios obtained after
subtracting background £uorescence were compared to ratios ob-
tained using a solution of indo-1 salt in saline and containing bu¡ers
of known [Ca2] ; this method gives results very similar to an in vivo
calibration [24]. The minimum ratio (Rmin), obtained by measuring
£uorescence from a Ca-free bu¡er was 0.2; the maximum ratio
(Rmax) obtained in micromolar Ca2-containing bu¡er was 3.5. Cel-
lular [Ca2] was then calculated from the equation using
440(R3Rmin)/(Rmax3R), where 440 is the dissociation constant in nM.
2.5. Materials
Fluorescent dyes were obtained from Molecular Probes Limited.
Collagenase was Worthington type I (supplied by CamBio, UK)
and protease Sigma type XIV. Other reagents were obtained from
Sigma, BDH or Boehringer Mannheim. RR was obtained from Sigma
as the crude preparation; no attempt was made to purify this to allow
comparison with previous studies where the crude preparation was
also used.
2.6. Statistical analyses
Statistical analyses were performed using Student’s t-test. Data are
presented as means þ S.E.M.
3. Results
In isolated rat myocytes, [Ca2]m is normally maintained at
a slightly lower concentration than that in the cytosol [7,8].
This did not change signi¢cantly even when cells were electri-
cally stimulated to contract at high (although physiological)
rates of 6 Hz (results not shown). However, superfusion with
0.25 WM noradrenaline, together with a stimulation rate of
6 Hz, did induce a signi¢cant increase in [Ca2]m (Fig. 1).
Under these conditions, [Ca2]m does not change during a
Fig. 1. The e¡ect of RR on mitochondrial Ca2 uptake. Single my-
ocytes were electrically stimulated to contract at a rate of 6 Hz in
presence of 0.25 WM noradrenaline in order to induce mitochondrial
Ca2 uptake. [Ca2]m was then measured using indo-1 £uorescence
(see Section 2), after reaching a peak (in about 1 min). When
present, RR was added 10 min before the start of the stimulation
protocol. n = 4^11 cells from 3^6 hearts in each group. *P6 0.05
versus 0 [RR].
Fig. 2. E¡ect of RR on [Ca2]i. Myocytes were subjected to the
same stimulation protocol as described for Fig. 1, except that total
[Ca2]i was determined using indo-1 £uorescence (see Section 2), for
diastolic and systolic [Ca2] (top panel), and the amplitude of the
Ca2 transient (systolic3diastolic, lower panel). n = 4^7 cells from
3^6 hearts in each group. *P6 0.05, **P6 0.01, ***P6 0.001 versus
corresponding value at 0 [RR].
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single contraction, but does increase more slowly, reaching a
maximum in approximately 1 min (see [8]). The e¡ect of var-
ious concentrations of RR on [Ca2]m was then tested using
this protocol. Fig. 1 shows that whereas 0.1 WM RR had no
signi¢cant e¡ect on the increase in [Ca2]m, both 0.5 and 1 WM
RR signi¢cantly reduced [Ca2]m.
In order to determine whether this was independent, or a
secondary consequence, of a decrease in [Ca2]c, the protocol
was repeated in cells where total [Ca2]i was measured. Fig. 2
(top panel) shows that the peak systolic [Ca2] was reduced by
all concentrations of RR, and 0.5 and 1 WM RR also reduced
diastolic [Ca2]. Since this method measures total [Ca2]i, it
could be argued that the decreases in diastolic and systolic
[Ca2] were simply a re£ection of the decreased [Ca2]m.
However, the observation that the amplitude of the Ca2
transient was also reduced by RR (Fig. 2, lower panel), in-
dicates that this is not the case. Furthermore, the maximum
cell shortening induced in response to high stimulation plus
noradrenaline was also reduced by RR at 0.5 and 1 WM,
indicating that RR was indeed a¡ecting [Ca2]c (Fig. 3).
In attempting to use higher concentrations of RR, it was
found that 5 WM completely inhibited cell contraction, where-
as at 10 WM and above, the cells underwent spontaneous
contractions and [Ca2]i oscillations, suggesting that RR has
a dual e¡ect on [Ca2]i.
In order to determine whether RR can in fact inhibit mi-
tochondrial Ca2 uptake, cells were exposed to a solution
containing low [Na], which induces cellular Ca2 overload
by reversal of the sarcolemmal Na/Ca2 exchanger, and con-
tributions of SR Ca2 transport were abolished using thapsi-
gargin. Fig. 4 shows that, using this procedure, a concentra-
tion of 25 WM RR was required to completely prevent the
increase in [Ca2]m ; this was not a secondary result of a
reduction in [Ca2]c since all cells underwent spontaneous
contractile oscillations, indicative of cytosolic Ca2 overload.
4. Discussion
The results of this paper indicate that, at low concentra-
tions (0.1^1 WM), the inhibition of mitochondrial Ca2 uptake
by RR is secondary to a reduction in cytosolic, notably sys-
tolic, [Ca2], suggesting an inhibition of Ca2 release from the
SR. This conclusion was supported by the ability of RR to
also inhibit cell shortening; indeed at 5 WM RR, cell contrac-
tion was completely abolished. Inhibition of mitochondrial
Ca2 uptake was observed at a [RR] of 25 WM in response
to a Ca2 loading protocol which was independent of SR
Ca2 release (Fig. 4). However, at 10 WM and above, RR
induced spontaneous Ca2 and contractile oscillations, which
are indicative of cytosolic Ca2 overload. Thus, RR appears
to have dual e¡ects on [Ca2]i ; at low concentrations RR
inhibits the release of Ca2 from the SR, and thus also inhib-
its cell contraction, whereas at higher concentrations, RR in-
duces cytosolic Ca2 overload. In either case, normal excita-
tion^contraction coupling is disrupted.
In previous studies, the concentrations of RR used have
varied greatly, from 0.025 to 50 WM [7,18^23,25^28]. Very
few of these studies have actually measured [Ca2]m, and of
those that have, concentrations in excess of 20 WM have gen-
erally been used to inhibit mitochondrial Ca2 uptake [7,25].
The e¡ects of lower concentrations were not reported in these
studies. In the other studies, where 0.025 to 5 WM RR were
used, e¡ects were attributed to its action as an inhibitor of
mitochondrial Ca2 uptake. However, the results of the
present study indicate that this is likely to be due to a sec-
ondary e¡ect of a reduced [Ca2]c, and not to an e¡ect on
mitochondrial Ca2 uptake per se.
The mechanism of the Ca2 overload induced by RR at
higher concentrations is not known. RR has also been found
to increase [Ca2]i in neuronal cells in a dose- and time-de-
pendent manner [29], and mitochondrial oxidative function
was also depressed by RR in this study. This latter observa-
tion agrees with previous work using isolated rat liver mito-
chondria which showed that high concentrations of RR in-
hibited respiration [30]. One explanation is that RR may act
as an electron carrier itself and transfer electrons from NADH
to cytochrome c, thus bypassing the normal pathways of res-
piration and oxidative phosphorylation [31]. Any such inhibi-
tion of ATP synthesis in the heart would be expected to result
in disruption of Ca2 homeostasis, and lead to eventual cyto-
Fig. 3. E¡ect of RR on maximal cell shortening. Cells were sub-
jected to the stimulation protocol described for Fig. 1. Cell length
was measured using an edge tracking device, and is expressed as
%(maximal shortening at peak stimulation)/(initial cell length).
n = 6^18 cells from 3^11 hearts in each group. *P6 0.05 versus 0
[RR].
Fig. 4. E¡ect of RR on [Ca2]m during a cell Ca2 overloading pro-
tocol. Cells were not stimulated and were pre-treated with 1 WM
thapsigargin prior to the experiment. Cells were then brie£y exposed
to ‘low Na’ solution (see Section 2) before returning to normal bu¡-
er. [Ca2]m was measured as described in Section 2, and results are
presented as raw data tracings from single cells (typical of three
such experiments).
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solic Ca2 overload. In addition, RR is a polycationic mole-
cule, and could conceivably displace bound intracellular Ca2
by a non-speci¢c action.
With the current interest in the role of [Ca2]m in many
aspects of physiological and pathological cell functioning,
RR is increasingly used with any e¡ects on cell function or
intracellular Ca2 signalling attributed to inhibition of mito-
chondrial Ca2 uptake. The results of the present study cau-
tion strongly against the indiscriminate use of this agent in
such studies, and that measurements of both cytosolic and
[Ca2]m should ideally be made before any conclusions can
be drawn.
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